Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of this cutting-edge extension in cancer therapy for radiation oncologists. It provides a general overview of targeted agents, reviews current clinical trials, and includes a look at the future of this state-of-the-art practice.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
William Small, Jr, MD is Professor of Radiation Oncology and Vice-Chairman of the Department of Radiation Oncology at Northwestern University. He is the Associate Medical Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and serves on the editorial board of the American Journal of Hematology/Oncology Review and Cancer News.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Literary Cat Books, Machynlleth, Powys, WALES, Vereinigtes Königreich
Original Printed boards. Zustand: Near Fine. First Edition; First Impression. Original red printed boards. Slight soiling to spine, covers and corners.; W/ b/w illustrations.; 26x18.2x1.6 cm; xiv, 226 pages. Bestandsnummer des Verkäufers 64078
Anzahl: 1 verfügbar
Anbieter: BOOKWEST, Phoenix, AZ, USA
Hardcover. Zustand: New. 1st Edition. US SELLER SHIPS FAST FROM USA. Bestandsnummer des Verkäufers 139D1-140C4-1933864346-150421-ORD-3
Anzahl: 1 verfügbar
Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEOCT25-230164
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Bestandsnummer des Verkäufers ABBB-51693
Anbieter: Books Puddle, Woodside, NY, USA
Zustand: New. pp. xiv + 226. Bestandsnummer des Verkäufers 261530286
Anzahl: 1 verfügbar
Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEOCT25-297804
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. xiv + 226 Illus. Bestandsnummer des Verkäufers 6350449
Anzahl: 1 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. pp. xiv + 226. Bestandsnummer des Verkäufers 181530276
Anzahl: 4 verfügbar
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
Hardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Bestandsnummer des Verkäufers ERICA77519338643466
Anzahl: 1 verfügbar
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Radiotherapy plays an integral role in Cancer treatment. Approximately 60% of Cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in Cancer therapy for Radiation Oncologists. Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of the current state of clinical and pre-clinical research in combining radiotherapy with targeted biological agents to fight Cancer. The text provides a general overview of targeted agents, reviews the current clinical trials, and includes a look at the future of this state-of-the-art practise. This book begins with a general overview of the topic, including an introduction to the subject; the basic science rationale behind the two most important current targeted agents: epidermal growth factor (EGFR) receptors and vascular epithelial growth factor (VEGF) receptors; the dermatologic manifestations of targeted agents; and an introduction to radioimmunotherapy a treatment that has the ability to combine targeted agents directly with radiotherapy. The second half of the book focuses on specific disease sites, including Malignant Gliomas, Head and Neck, Lung, Pancreatic, Cervical and Endometrial Cancers. Biologically targeted agents promise to be the next significant breakthrough in Cancer therapy. Written by leading experts in the field, Combining Targeted Biological Agents with Radiotherapy is a comprehensive evaluation of the entire field. This text is an overview of the current state of clinical and pre-clinical research in combining radiotherapy with targeted biological agents to fight cancer. The text provides a general overview of targeted agents, reviews the current clinical trials, and includes a look at the future of this state-of-the-art practice. This book begins with a general overview of the topic, including an introduction to the subject; the basic science rationale behind the two most important current targeted agents: epidermal growth factor (EGFR) receptors and vascular epithelial growth factor (VEGF) receptors; the dermatologic manifestations of targeted agents; and an introduction to radioimmunotherapy???a treatment that has the ability to combine targeted agents directly with radiotherapy. The second half of the book focuses on specific disease sites, including malignant gliomas, head and neck, lung, pancreatic, cervical, and endometrial cancers. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9781933864341